Filterlex Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Later Stage VC
- Investors
-
7
Filterlex General Information
Description
Developer of cardiovascular embolic protection devices designed for use during transcatheter aortic valve implantation procedures. The company's platform incorporates full-body embolic protection technology, compatibility with various catheter sizes, and ease of integration into existing workflows, enabling physicians to reduce the risk of embolic events and improve patient safety during minimally invasive heart valve replacement procedures.
Contact Information
Website
www.filterlex.comCorporate Office
- 9 Khalamish Street
- Caesarea Industrial Park
- Yokneam 3089900
- Israel
Corporate Office
- 9 Khalamish Street
- Caesarea Industrial Park
- Yokneam 3089900
- Israel
Filterlex Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 01-Jul-2024 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 21-Dec-2021 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series A1) | 18-Nov-2021 | Completed | Generating Revenue | |||
| 5. Grant | 16-Sep-2019 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 15-Jul-2019 | Completed | Generating Revenue | |||
| 3. Grant | 01-Jan-2019 | Completed | Generating Revenue | |||
| 2. Grant | 01-Nov-2018 | $56K | $900K | Completed | Generating Revenue | |
| 1. Seed Round | 01-Jun-2016 | $900K | $900K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Filterlex Patents
Filterlex Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024209464-A1 | Embolic protection device and delivery and retrieval catheters | Inactive | 04-Apr-2023 | ||
| AU-2019273861-A1 | Intra-aortic embolic protection filter device | Active | 22-May-2018 | ||
| AU-2019273861-B2 | Intra-aortic embolic protection filter device | Active | 22-May-2018 | ||
| AU-2025200174-A1 | Intra-aortic embolic protection filter device | Pending | 22-May-2018 | ||
| EP-3796868-A1 | Intra-aortic embolic protection filter device | Inactive | 22-May-2018 | A61F2/0105 |
Filterlex Signals
Filterlex Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Club 100 plus | Angel Group | Minority | ||
| Katao Venture Partners | Venture Capital | Minority | ||
| Besadno Group | Asset Manager | Minority | ||
| Meir Kfir | Corporation | Minority | ||
| The Jon Holden DeHaan Foundation | Impact Investing |
Filterlex FAQs
-
When was Filterlex founded?
Filterlex was founded in 2015.
-
Where is Filterlex headquartered?
Filterlex is headquartered in Yokneam, Israel.
-
What is the size of Filterlex?
Filterlex has 12 total employees.
-
What industry is Filterlex in?
Filterlex’s primary industry is Surgical Devices.
-
Is Filterlex a private or public company?
Filterlex is a Private company.
-
What is Filterlex’s current revenue?
The current revenue for Filterlex is .
-
How much funding has Filterlex raised over time?
Filterlex has raised $17.8M.
-
Who are Filterlex’s investors?
Club 100 plus, Katao Venture Partners, Besadno Group, Meir Kfir, and The Jon Holden DeHaan Foundation are 5 of 7 investors who have invested in Filterlex.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process